SWITZERLAND/CEE – PEF invests EUR 35m in PharmaSwiss

PharmaSwiss provides a range of registration, sales and marketing services to the pharmaceutical industry in Central and Eastern Europe, primarily for large pharmaceutical companies that are optimizing their marketing resources and biotechnology companies focusing their marketing activities on larger markets. The company has experienced high growth in recent years and currently generates revenues of more than EUR 100m.

The expansion financing from PEF, possibly combined with other sources of capital, will facilitate geographical expansion, with Russia/CIS and Turkey representing significant market opportunities. In addition, it will allow PharmaSwiss to expand its portfolio through product acquisitions.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• CEE